Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes

Version 1 : Received: 23 June 2023 / Approved: 26 June 2023 / Online: 26 June 2023 (14:18:45 CEST)

A peer-reviewed article of this Preprint also exists.

Jiang, X.; Fielding, L.A.; Davis, H.; Carroll, W.; Lisic, E.C.; Deweese, J.E. Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes. Int. J. Mol. Sci. 2023, 24, 12010. Jiang, X.; Fielding, L.A.; Davis, H.; Carroll, W.; Lisic, E.C.; Deweese, J.E. Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes. Int. J. Mol. Sci. 2023, 24, 12010.

Abstract

Topoisomerases, common targets for anti-tumor therapeutics, are crucial enzymes for DNA replication, transcription, and many other aspects of DNA metabolism. The potential anti-cancer effect of thiosemicarbazones (TSC) and metal-TSC complexes has been demonstrated by targeting several biological processes, including DNA metabolism. Human topoisomerases were discovered among the molecular targets for TSCs, and metal-chelated TSCs specifically displayed significant inhibition. The processes by which metal-TSCs or TSCs inhibit topoisomerases are still being studied. In this brief review, we summarize the TSCs and metal-TSCs that inhibit various types of human topoisomerases.

Keywords

topoisomerase; thiosemicarbazone; cancer; DNA

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.